Details of the Drug

General Information of Drug (ID: DM1RDPO)

Drug Name
SelG2
Indication
Disease Entry ICD 11 Status REF
Sickle-cell disorder 3A51 Phase 2 [1]
Cross-matching ID
TTD ID
D0A2BS

References

1 Clinical pipeline report, company report or official report of Selexys Pharmaceuticals.